# Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers

> **NCT07120269** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Thomayer University Hospital** · enrollment: 500 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Nasal swab to collect material for RT-PCR SAA evaluation

## Key facts

- **NCT ID:** NCT07120269
- **Lead sponsor:** Thomayer University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-10
- **Primary completion:** 2023-06-26
- **Final completion:** 2026-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07120269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07120269, "Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07120269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*